Illinois State University

ISU ReD: Research and eData
Faculty Publications – Chemistry

Chemistry

1-2008

Use of Di- and Tripropionate substrate analogs to
probe the active site of human recombinant
coproporphyrinogen oxidase
Justin B. Morgenthaler
Illinois State University

Reyna L. Barto
Illinois State University

Timothy D. Lash
Illinois State University

Marjorie A. Jones
Illinois State University

Follow this and additional works at: https://ir.library.illinoisstate.edu/fpchem
Part of the Condensed Matter Physics Commons
Recommended Citation
Morgenthaler, Justin B.; Barto, Reyna L.; Lash, Timothy D.; and Jones, Marjorie A., "Use of Di- and Tripropionate substrate analogs to
probe the active site of human recombinant coproporphyrinogen oxidase" (2008). Faculty Publications – Chemistry. 3.
https://ir.library.illinoisstate.edu/fpchem/3

This Article is brought to you for free and open access by the Chemistry at ISU ReD: Research and eData. It has been accepted for inclusion in Faculty
Publications – Chemistry by an authorized administrator of ISU ReD: Research and eData. For more information, please contact ISUReD@ilstu.edu.

Illinois State University

ISU ReD: Research and eData
Chemistry Department

Arts and Sciences

1-1-2008

Use of Di- and Tripropionate substrate analogs to
probe the active site of human recombinant
coproporphyrinogen oxidase
Justin B. Morgenthaler
Illinois State University

Reyna L. Barto
Illinois State University

Timothy D. Lash
Illinois State University

Marjorie A. Jones
Illinois State University

Follow this and additional works at: http://ir.library.illinoisstate.edu/chem
Part of the Chemistry Commons
Recommended Citation
Morgenthaler, Justin B.; Barto, Reyna L.; Lash, Timothy D.; and Jones, Marjorie A., "Use of Di- and Tripropionate substrate analogs to
probe the active site of human recombinant coproporphyrinogen oxidase" (2008). Chemistry Department. Paper 1.
http://ir.library.illinoisstate.edu/chem/1

This Article is brought to you for free and open access by the Arts and Sciences at ISU ReD: Research and eData. It has been accepted for inclusion in
Chemistry Department by an authorized administrator of ISU ReD: Research and eData. For more information, please contact ISUReD@ilstu.edu.

WWW. M ED S CI M ONIT .COM

Basic Research

Use of Di- and Tripropionate substrate analogs
to probe the active site of human recombinant
coproporphyrinogen oxidase

Authors’ Contribution:
A Study Design
B Data Collection
C Statistical Analysis
D Data Interpretation
E Manuscript Preparation
F Literature Search
G Funds Collection

Justin B. MorgenthalerABDE, Reyna L. BartoAB, Timothy D. LashADEF,
Marjorie A. JonesADEFG

A
L

U
SE

Received: 2007.10.05
Accepted: 2007.11.09
Published: 2008.01.01

Department of Chemistry, Illinois State University, Normal, IL, U.S.A.

O
N

Source of support: This work was supported by an Illinois State University Research Grant to M.A.J

Summary

Defects in the enzyme coproporphyrinogen oxidase result in accumulation of porphyrins which
may affect the severity of a subset of porphyrias. Thus evaluation of this enzyme for substrate selectivity is of value. Kinetic evaluations of recombinant human coproporphyrinogen oxidase have
been undertaken using six di- and tripropionate analogs of the natural substrate coproporphyrinogen-III. These substrate analogs were modiﬁed by having alkyl groups in place of one or both of
the ring 13- or 17-propionate moieties.

Material/Methods:

Cloned human enzyme was incubated with analogs under apparent ﬁrst order conditions and with
various substrate concentrations. The kinetic values, Km and Vmax, were determined.
Relative to the authentic substrate, the Km values for the 13-ethyl, dimethyl and diethyl porphyrinogens were very comparable whereas the Km values were much higher using dipropyl and dibutyl porphyrinogen and much lower for the 17-ethyl analog. For the dipropionate analogs, the Vmax
values were an apparent function of the carbon length of the substituent on the C and D rings,
with longer carbon length severely reducing product formation by some 4–5 orders of magnitude.
Also, the two isomeric tripropionates that were tested indicated that it was more detrimental to
have an ethyl group at the 13-position for both binding and catalysis.
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This work extends our understanding of porphyrin ring substituent effects reported by Cooper
et al. (2005). The substituents on both the C and D rings have signiﬁcant effects on both the substrate binding and catalysis by this important enzyme.
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MATERIAL AND METHODS

Isolation and puriﬁcation of human recombinant
copro’gen oxidase

The human cloned his-tagged enzyme was expressed in
Escherichia coli with the vector pET21d-CO containing the lac
operon to better control enzyme production [5]. The E. coli
were grown (overnight, 37°C, with shaking) in a liter of media consisting of 10 g tryptone (Fisher Chemical Company),
5 g yeast extract (Sigma Chemical Company), 10 g NaCl, 50
μg/ml ampicillin, and 34 μg/ml chloramphenicol (Sigma
Chemical Company). To yield a higher concentration of
protein, the cells were induced with 1 mM isopropyl-b-Dthiogalactoside (IPTG) after the initial 24 hours of growth
then allowed to grow for an additional 3 hours. Cells were
centrifuged (10 min at 11,900 × g), and resuspended in 60
ml of resuspension buffer containing 0.0105 g of phenylmethylsulfonylﬂuoride (Sigma Chemical Company), 12.1
g/L Trisma base, 6.9 g/L NaH2PO4, and 17.5 g/L NaCl, pH
8 then lysed using a French® hydraulic pressure cell (SimAminco Spectronic Instruments) at 20,000 psi. The lysate
was centrifuged for 30 min at 27,200 × g. The resulting supernatant was applied to a nickel afﬁnity column (Qiagen),
and the his-tagged enzyme was eluted with resuspension buffer containing 250 mM imidazole following the method of
Medlock and Dailey [10]. The Bradford Protein Assay [11]
using bovine serum albumin (BSA) as a standard was used
to evaluate the concentration of the eluted protein.
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The enzyme coproporphyrinogen oxidase (copro’gen oxidase, EC 1.3.3.3) is the sixth enzyme in the biosynthetic
pathway for the production of heme [1]. Heme, when coupled to a globular protein, is the principal molecular oxygen carrier through out the body [1]. Malfunctions in the
gene encoding copro’gen oxidase as well as other enzymes
in this pathway, such as delta-aminolevulinic acid synthase,
can cause a build up of porphyrins and ultimately lead to
a category of diseases called porphyrias [2]. The authentic substrate for copro’gen oxidase is coproporphyrinogenIII (copro’gen-III) which undergoes two sequential oxidative decarboxylations to yield the protoporphyrinogen-IX
(proto’gen-IX) product. The overall reaction catalyzed by
copro’gen oxidase is shown in Figure 1. The mechanism by
which copro’gen oxidase carries out the sequential oxidative decarboxylations is as yet unknown, although some studies on ring substituent effects on substrate selectivity have
been reported (reviewed by Jones and Lash [3]). A model,
Figure 2, of substrate binding was developed from the data
obtained using substrate analogs [4]. This particular model
indicates that there are a minimum of two binding sites, X
and Z, as well as a catalytic site, Y. The model proposes that
oxidative decarboxylations occur at the catalytic site and
the substrate position is stabilized by the X and Z sites. The
Z site can only accommodate a relatively small alkyl group
such as a vinyl, methyl or hydrogen. The X site requires a
charged group such as a propionate, and it was postulated
that the substituent interacts with a positively charged amino acid. Recently, using site directed mutagenesis, arginine
262 and 401 were reported to be involved in substrate binding [5]. These binding requirements favor the sequence of
peripheral substituents R Me P Me P (R=methyl, vinyl, or H,
Me=methyl, P=propionate) for catalysis [4]. After the ﬁrst
oxidative decarboxylation on the A ring of copro’gen-III,
the authentic monovinyl intermediate harderoporphyrinogen (hardero’gen) is generated. The model purposed by
Lash et al. [4] suggests that a 90° clockwise turn is required
to put the B ring of hardero’gen in the correct position for
the second oxidative decarboxylation to generate the divinyl product, proto’gen-IX. Although it has been reported
that copro’gen oxidase is a homodimer, each monomer appears to have its own active site [6,7].

the di- and tripropionate analogs. The kinetic constants are
compared with previous data obtained using the chicken
red blood cell enzyme. Using recombinant enzyme, time
course studies were performed with each analog to determine the apparent ﬁrst order conditions to determine the
Km and Vmax values reported here. Also kcat and kcat/Km values were calculated.
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To better evaluate substrate recognition of the active site of
human copro’gen oxidase the use of substrate analogs that
differ at the C and D ring positions have been employed.
The analogs were synthesized by replacing propionates on
the C and/or D ring positions with methyl, ethyl, propyl,
or butyl groups [4,8]. Thus substituent effects of carbon
chain length and loss of the carboxylate group could be
evaluated. The porphyrinogens that were tested are shown
in Figure 3. Previous studies using these di- and tripropionate substrates were done with a crude copro’gen oxidase
preparation obtained from chicken red blood cells (CRBC)
[4,8,9]. However, data evaluation was difﬁcult since endogenous proto’gen-IX was present in these enzyme preparations. This endogenous product presented a challenge to
quantitate the amount of newly formed product being produced from the enzyme assays. However, with the use of
the recombinant human copro’gen oxidase, that particular challenge is eliminated. We now report the kinetic evaluation using highly puriﬁed recombinant enzyme using

Enzyme assay
Recombinant human copro’gen oxidase was assayed using
the micro method of Jones et al. [12]. In a ﬁnal reaction volume of 300 μL, puriﬁed enzyme (15 μg) was incubated with
10 μL of the various freshly reduced substrate analogs (Figure
3) to give a ﬁnal concentration of 0.8 μM; the dipropionate
analogs [mesoporphyrinogen-VI (meso’gen-VI, diethyl porphyrinogen), dimethyl, dipropyl, and dibutyl] and tripropionate analogs [13-ethyl, 17-ethyl] were incubated at 0.5, 1, 2,
5, 10, 30, 60, or 120 minutes to determine the initial velocity
(V0). Zero time incubations were also done as substrate stability controls. Substrate concentration was also varied under
initial velocity conditions for the kinetic analysis. Reactions
were carried out at 37°C, stopped with 3/7 (v/v) ethyl acetate/acetic acid, neutralized with 3% sodium acetate, extracted
and Fischer esteriﬁed overnight. After esteriﬁcation, porphyrins were neutralized, extracted, then separated using High
Performance Liquid Chromatography (HPLC) (Beckman
System Gold). A normal phase column (Beckman Silica 5 μ,
4.6 mm × 25 cm) was used with a mobile phase of 20/80 (v/v)
ethyl acetate/cyclohexane at a ﬂow rate of 1.3 ml/min; eluates
were evaluated spectrophotometrically at 404 nm. Data were
analyzed using the Gold Nouveau Software and reported as
nmol product/min/pmol enzyme. Graphic analysis and calculated values were obtained using SigmaPlot 2000.
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Figure 1. Overall reaction catalyzed by copro’gen
oxidase of coproporphyrinogen-III to
protoporphyrinogen-IX through the two
sequential oxidative decarboxylations.
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kcat/Km were calculated (Table 1). Each dipropionate analog used resulted in a formation of only monovinyl product (Figure 3). Of the two tripropionates, only the 17-ethyl resulted in signiﬁcant divinyl product formation whereas
only the monovinyl product was generated as a major product following incubation with the 13-ethyl porphyrinogen.
With the 13-ethyl analog, however, a second oxidative decarboxylation resulting in a divinyl product was noted as a
minor product at longer incubation times (greater than 30
min; Figure 3). The apparent binding afﬁnities (Km values)
for different substrates varied from 0.011 to 11.0 μM with
the 17-ethyl analog having the best afﬁnity for the recombinant copro’gen oxidase, while the dipropyl and dibutyl
analogs had the worst. Maximum velocities for each substrate analog varied widely from 3.6×10–7 to 1.7×10–3 nmol
product/min/pmol enzyme with the lowest value for the
dibutyl analog and the highest value for the 13-ethyl analog. The values for kcat, a measurement of catalytic turnover, exhibited a range of 3.6×10–4 to 1.7 min–1 with dibutyl having the lowest value and 13-ethyl having the largest
value. The catalytic efﬁciency, kcat/Km, values varied over a
very wide range from 3.4×10–5 for the dibutyl analog to 9.1
min–1 μM–1 for the 17-ethyl analog.
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DISCUSSION
Figure 2. Active Site Model of Copro’gen Oxidase [4].

RESULTS
Kinetic analysis
Shown in Figures 4–9 are the graphical representations of
Vo (nmol product/min/pmol recombinant enzyme) as a
function of substrate concentration (μM) for all the substrate analogs tested. From these graphs Km, Vmax, kcat and

The human recombinant copro’gen oxidase recognized all
of the substrate analogs studied but was only able to carry out the ﬁrst oxidative decarboxylation with the dipropionate analogs. The tripropionate 17-ethyl porphyrinogen
gave divinyl product with little of the intermediary monovinyl species being detected. The isomeric 13-ethyl porphyrinogen gave mostly the monovinyl product. Nevertheless, the
observation that longer incubation times with the 13-ethyl
analog resulted in some minor amount of divinyl product
being generated is signiﬁcant. When comparing all the dipropionate substrates, the dibutyl analog was the least well
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Figure 3. Structure of Di- and Tri-propionate
Porphyrinogen Analogs.
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Divinyl porphyrinogens
For 17-Ethyl (R1=P; R2=Et), this is the only observed product.
For 13-Ethyl (R1=Et; R2=P), this is a minor product. The products
were analyzed as the coresponding porphyrin methyl esters.
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Figure 4. The formation of monovinyl product as a function of diethyl
concentration (Incubation time – 0.5 min, mean ±standard
deviation, n=3 replicates).

Figure 5. The formation of monovinyl product as a function of 13
Ethyl concentration (Incubation time – 0.5 min, mean
±standard deviation, n=3 replicates).

processed. The Vmax for the dibutyl was almost 30 fold lower than that of the dipropyl and 3–4 orders of magnitude
worse than the largest Vmax value, 13-ethyl. Also, the Km value was 10–12 times larger than the best analog, indicating
that the binding of this dibutyl analog is severely compromised. With these bulky propyl and butyl groups present
on both the C and D rings, it was predicted that the binding afﬁnity would be affected. However, when comparing

the Km values of the dipropyl and dibutyl analogs, the values were the same implying a similar poor ﬁt into the active
site. The two analogs differ in their Vmax values with the dipropyl having a higher Vmax value. These data indicated that
the extra methylene group on each of the C and D rings in
the dibutyl slows down catalysis with no apparent difference
in binding. When comparing the dipropyl and dibutyl to
the kinetics obtained using diethyl (meso’gen-VI), the Vmax
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Figure 6. The formation of divinyl product as a function of 17 Ethyl
concentration (Incubation time – 1.0 min, mean ±standard
deviation, n=3 replicates).
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Figure 8. The formation of monovinyl product as a function of
DiMethyl concentration (Incubation time – 0.5 min, mean
±standard deviation, n=3 replicates).

Figure 9. The formation of monovinyl product as a function of
DiPropyl concentration (Incubation time – 120 min, mean
±standard deviation, n=3 replicates).

for the diethyl porphyrinogen was about 3 orders of magnitude faster than that with the dipropyl and 4 orders faster
than with the dibutyl analog. The Km values for the analogs
also varied by a factor of 3–4 with diethyl having a Km value
of 0.56 μM and the dipropyl and dibutyl analogs both having values of 11 μM. It appears that the binding afﬁnity as
well as catalysis is more favorable with shorter alkyl substituents present on both the C and D rings. This observation
was further supported by the results for the dimethyl substrate analog. The Km value for dimethyl was 0.11 μM and
the maximum velocity was found to be about the same as
that of the diethyl analog. Interestingly, at higher concentrations of dimethyl this analog appeared to show inhibitory effects while the other analogs did not. With good binding afﬁnity but moderate catalysis, the dimethyl analog at
high concentrations may, in effect, occupy the active site
for a longer time before it can undergo catalysis creating
the apparent inhibitory effect.

The kinetic data presented here for the dipropionate analogs indicate that the shorter the carbon chain substituent
present on the C and D ring the better the kinetic constants.
Comparisons of kinetic constants of the crude chicken red
blood cell (CRBC) enzyme preparation to the recombinant
human copro’gen oxidase show a similar inhibitory trend
as the substituent carbon length on the C and D rings is increased (Figure 10 and Table 2). However, the Vmax values
for the crude CRBC enzyme [9] are about half of the values
for the human recombinant copro’gen oxidase.
The tripropionate analogs were synthesized with an ethyl
group on either the C or D ring at the 13 or 17 positions. The
13-ethyl analog primarily underwent the ﬁrst oxidative decarboxylation and a divinyl product was only formed to a minor
extent. However, moving the ethyl group over to the 17-position resulted in detection of only divinyl product. Since the
monovinyl product is an obligatory intermediate, we interpret
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tectable under our experimental conditions using the 17-ethyl
analog. When comparing the Km values of the tripropionates,
17-ethyl had a Km value of 0.011 μM which was surprisingly
lower than the value for the authentic substrate. In contrast,
the 13-ethyl had a Km of 0.85 μM which is very similar to that
using the authentic substrate. It is clear that replacement of
the propionate by an ethyl group at the 17-position affects
the binding afﬁnity more positively than the ethyl group at
the position 13. However, the maximum velocity using 13-ethyl was more than an order of magnitude faster than the Vmax
using the 17-ethyl. It is not apparent why the Vmax should be
so variable between these isomeric analogs.

Vmax (μM/min) as a function of carbon lenght
0.35
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SE

0.30
Vmax (μM/min)

0.25
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As had been observed in incubations with the dimethyl porphyrinogen, the use of the 17-ethyl analog showed an apparent inhibition of product formed as a function of substrate
concentration. This inhibition was seen at lower concentrations (between 1–2 μM) than with the dimethyl (3–6 μM).
This difference in concentration dependence could be explained by the differences in the binding afﬁnity between
each substrate. The Km value for dimethyl was 0.11 μM which
was 10-fold higher than the 0.011 μM value for the 17-ethyl
analog. Since these Km values are for the formation of monovinyl (using dimethyl) or divinyl product (using 17-ethyl), this may imply that the divinyl product is more able to
affect interaction of enzyme with substrate.
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Figure 10. Comparison of Vmax values for human recombinant
copro’gen oxidase (z) and chicken red blood cell copro’gen
oxidase ({) [9].

TI

these data to indicate that the ﬁrst oxidative decarboxylation
is slower than the second reaction which supports the work of
Elder et al. [13]. Thus only the second (divinyl) product is de-

Table 1. Kinetic constants for substrate analogs incubated with the human recombinant copro’gen oxidase.
Product
Divinyl

Copro’gen-III**

Km (μM)

kcat (min–1)

kcat/Km

–3

0.70

3.3

4.7

–3

0.68

3.6

5.3

–3

Vmax*

C
A

Substrate

3.3×10

3.6×10

13-Ethyl

Monovinyl

1.7×10

0.85

1.7

2.0

17-Ethyl

Divinyl

1.0×10–4

0.011

0.10

9.1

U

Total

Monovinyl

5.0×10–4

0.11

0.050

0.45

Monovinyl

3.8×10-4

0.56

0.38

0.68

diPropyl

Monovinyl

9.9×10–6

11.0

9.9×10–3

9.1×10–4

diButyl

Monovinyl

3.6×10–7

11.0

3.6×10–4

3.4×10–5

diMethyl
diethyl
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* Vmax – nmol product/min/pmol Enzyme; ** Cooper et al., 2005 [14].
Table 2. Comparison of human recombinant copro’gen oxidase and chicken red blood cells kinetic constants (using same units of activity) for the diand tripropionate analogs.
Vmax*
Substrate

Km (μM)

HCPO

CRBC

HCPO

CRBC

13-Ethyl

2.6

0.21

0.85

2.0

17-Ethyl

0.048

0.055

0.011

0.88

diMethyl

0.33

0.14

0.11

1.0

diEthyl

0.24

0.095

0.56

0.99

diPropyl

0.0064

0.012

11.0

0.35

diButyl

0.00030

0.00011

11.0

0.10

* Vmax – μM Product/min; CRBC – Chicken Red Blood Cell Hemolysates [9]; HCPO – Human Recombinant Copro’gen Oxidase.
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2. Moore MR: Biochemistry of Porphyria. Int J Biochem, 1993; 25:
1353–68

It is apparent from these studies that the substituents on the
C and D rings of the porphyrin are necessary for not only
proper binding but also efﬁcient catalysis. As the substituent
hydrocarbon length was increased, on both the C and D rings,
the enzyme kinetics were hindered relative to the authentic
substrate. However, the tripropionate substrate analogs resulted in better binding afﬁnity in the case of the 17-ethyl,
and an increased rate of catalysis in the case of the 13-ethyl
substitution. The formation of some divinyl product in the
13-ethyl case was unexpected and suggests that binding to
site X by a propionate moiety in the active site model is not
an absolute requirement for catalysis. It was interesting to
note that the largest kcat/Km value (catalytic efﬁciency) value was calculated using the 17-ethylporphyrinogen as substrate. These data indicate that substituents on both the 13and 17-ring positions of the substrate have important roles in
binding and catalysis of substrate by the enzyme copro’gen
oxidase. Thus the early model of the active site needs revision to account for these effects. As indicated in the work by
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